Tools for Practice Outils pour la pratique


#386 The Bland Supremacy: Salt and cardiovascular disease


CLINICAL QUESTION
QUESTION CLINIQUE
Does reducing sodium intake or substituting table salt with sodium-potassium alternatives improve cardiovascular outcomes?


BOTTOM LINE
RÉSULTAT FINAL
Based on one large randomized, controlled trial (RCT) in patients with hypertension/previous stroke with above average daily salt intake (example 4.8 g/day), replacing table salt with a salt substitute may decrease mortality (from ~4.5% to ~4%) and stroke (from ~3.5% to 3%) per year. Whether reducing sodium by other means reduces mortality or cardiovascular events is unknown.



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
  • Results statistically significant unless indicated.
  • Table salt substitution (75% sodium-chloride/25% potassium-chloride), largest RCT:1
    • 20,995 participants from rural China (age ~65, mean blood pressure ~154/89, 73% with stroke history, sodium intake ~4.8g at baseline),2 estimated incidence per year:
      • Mortality: ~4% (salt substitution) versus ~4.5 % (usual salt), Number Needed to Treat (NNT)=200.
      • Strokes: ~3% (salt substitution) versus ~3.4 % (usual salt), NNT=250.
      • Systolic blood pressure: Reduced by 3.3mmHg (salt substitution) compared to continuing regular salt.
      • Limitation: Likely higher than average salt intake.
  • Four systematic reviews (including above trial) showed similar results for mortality.3-6
  • Adverse effects:
    • Serum potassium: 0.12-0.18mmol/L higher with salt substitution.3,6
    • Overall, few cases severe hyperkalemia/worsening renal function. 3,6
    • Limitations: Severe kidney disease excluded.1
  • Sodium reduction: No RCT powered to detect change in mortality/cardiovascular events.7,8

CONTEXT
CONTEXTE
  • Guidelines:
    • Recommend sodium reduction (example: <2g/day) but there is no reliable way for patients to estimate sodium consumption.9
    • Average sodium intake (Canadians): ~2.7-3.6g/day.10,11
  • In Canada, 75% sodium-chloride/25% potassium-chloride not available. Products with different blends of salt and potassium chloride (containing 50% less sodium than regular salt) are available (example: Half-SaltTM).
  • Blood pressure:
    • RCT: Lowering sodium intake (~3.6 to ~2.6 grams/day) reduces BP by ~4mmHg at 2.5 years.7,8 However, this was achieved with coaching to reduce sodium; unknown if brief interventions/self-help materials helpful long-term.
    • Effect of sodium substitution/reduction on blood pressure is comparable to blood-pressure medications.12
  • If processed food important source of sodium intake (common in North America, but not rural China), salt substitution/reduction may have less impact.
  • Focusing on healthier food choices important; the Mediterranean diet has been shown to reduce the risk of cardiovascular events.13


Latest Tools for Practice
Derniers outils pour la pratique

#386 The Bland Supremacy: Salt and cardiovascular disease

Does reducing sodium intake or substituting table salt with sodium-potassium alternatives improve cardiovascular outcomes?
Read Lire 0.25 credits available Crédits disponibles

#385 Topical minoxidil for androgenetic alopecia: When blood pressure agents make you hairy

How effective is topical minoxidil for androgenetic alopecia?
Read Lire 0.25 credits available Crédits disponibles

#384 Treatment of PTSD Nightmares: Is prazosin a dream come true?

How effective is prazosin for nightmares in posttraumatic stress disorder (PTSD)?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • Émélie Braschi MD PhD CCFP
  • Jennifer Young MD CCFP-EM

1. Neal B, Wu Y, Feng X et al. N Engl J Med. 2021 Sep 16;385(12):1067-1077.

2. Yin X, Paige E, Tian M et al. Hypertension. 2023 May;80(5):956-965.

3. Greenwood H, Barnes K, Clark J et al. Ann Intern Med. 2024 May;177(5):643-655.

4. Yin X, Rodgers A, Perkovic A et al. Heart. 2022 Sep 26;108(20):1608-1615.

5. Tsai YC, Tsao YP, Huang CJ et al. J Clin Hypertens (Greenwich). 2022 Sep;24(9):1147-1160.

6. Brand A, Visser ME, Schoonees A et al. Cochrane Database of Syst Rev 2022, Aug 10;8(8):CD015207.

7. Adler A, Taylor F, Martin N et al. Cochrane Database Syst Rev. 2014 Dec 18;2014(12):CD009217.

8. Whelton PK, Appel LJ, Espeland WB et al. JAMA. 1998 Mar 18;279(11):839-46.

9. O’Donnell M, Mente A, Alderman M et al. Eur Heart J. 2020 Sep 14;41(35):3363-3373.

10. Sodium Intake of Canadians in 2017. Health Canada. Available online at https://www.canada.ca/content/dam/hc-sc/documents/services/publications/food-nutrition/sodium-intake-canadians-2017/2017-sodium-intakes-report-eng.pdf. Accessed September 18-2024.

11. Mean salt intake in adults aged 25 years and older in the Americas, 1990-2019. ENLACE Data Portal. Pan American Health Organization, 2023. Available online at https://www.paho.org/en/enlace/salt-intake. Accessed September 18-2024.

12. McLean R. Cochrane Database Syst Rev. 2022 Aug 18;8(8):ED000158.

13. Kolber MR, Klarenbach S, Cauchon M et al. Canadian Family Physician. 2023 Oct;69(10)675-686.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.